Clinical Lecture Explores Role of Contrast Management
In Slowing Myopia Progression
Optometrists and dispensing opticians attending 100% Optical in London are invited to attend a clinical lecture examining the growing evidence base for contrast management as a mechanism to slow myopia progression.
Professor James Wolffsohn, Head of Optometry at Aston University and Chief Clinical Scientist for the International Myopia Institute, will present “Managing contrast to slow myopia progression,” on Saturday, 28 February.
Widely recognised for his contributions to optometric research and education, Professor Wolffsohn will present insights that shed new light on long-held assumptions about the visual signals that influence eye growth, and explain how these findings contribute to the scientific basis for DOT® spectacle lenses, which provide myopia control through contrast management.
DOT lenses are the first myopia management treatment specifically designed to reduce retinal contrast signaling through the incorporation of light scattering elements.1 The lenses have been shown to reduce myopia progression by up to 75% after 12 months of wear across diverse populations,1, 2,* and are effective for children as young as six.2, 3
The presentation will address three key questions currently shaping clinical discussion in myopia management: what is the evidence base for contrast management in myopia treatment, how does contrast management relate to defocus-based interventions, and what is the clinical relevance for everyday optometric practice?
“Managing contrast to slow myopia progression” takes place on 28 February from 12:00 to 13:00 as part of the 100% Optical Seminar Programme. More information about the lecture is available here.
###
*Patient population aged 6–10 years (CYPRESS) and 6–13 years (CATHAY). Prescribed DOT lens wear time was 10 hours per day.
SightGlass Vision® products are not available for sale in the United States.
Media Contact
Carson Daniels, Senior Counselor
McDougall Communications for SightGlass Vision
+1-315-427-6394 or [email protected]